Neoadjuvant endocrine therapy in postmenopausal women with HR+/HER2- breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant endocrine therapy in postmenopausal women with HR+/HER2- breast cancer

Published:2023-01-02 Issue:1 Volume:23 Page:67-86
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Martínez-Pérez Carlos¹²,Turnbull Arran K¹²,Kay Charlene¹²,Dixon J Michael¹²³

Affiliation:

1. Translational Oncology Research Group, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, Scotland

2. Edinburgh Breast Cancer Now Research Team, MRC Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, Scotland

3. Edinburgh Breast Unit, Western General Hospital, Edinburgh, Scotland

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2023.2162043

Reference194 articles.

1. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.

2. Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer

3. The evolving role of receptors as predictive biomarkers for metastatic breast cancer

4. Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immune microenvironment characterisation and dynamics in hormone receptor–positive breast cancer before and after neoadjuvant endocrine therapy;Cancer Medicine;2023-08-08

2. Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact;Breast Cancer Research and Treatment;2023-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3